F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.
about
Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancerThe use and misuse of positron emission tomography in lung cancer evaluation18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions.The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.Lung cancer 7: management of lung cancer in elderly patients.Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Metabolic response assessment with (18)F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancer.Should positron emission tomography/computed tomography be the first rather than the last test performed in the assessment of cancer?Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancerThe role of PET/CT scanning in radiotherapy planning.Routine use of positron-emission tomography/computed tomography for staging of primary colorectal cancer: does it affect clinical management?Quality assurance of positron emission tomography/computed tomography for radiation therapy.18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.The role of PET in target localization for radiotherapy treatment planning.The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.PET/CT in radiation oncology.PET and PET-CT in radiation treatment planning for lung cancer.Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.Modern diagnostic and therapeutic interventional radiology in lung cancer.The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.Improving radiation therapy for non-small cell lung cancer: molecular imaging and a team-based approach.Research and development of radiation therapy in clinical routines.Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer.Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients.Conformal radiotherapy and molecular imaging: complementary technologies in cancer therapy.Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.Incorporating PET information in radiation therapy planning.PET/CT: will it change the way that we use CT in cancer imaging?Health technology assessment and cancer imaging: who should be setting the agenda?Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.Screening and Biosensor-Based Approaches for Lung Cancer Detection.An iterative technique to segment PET lesions using a Monte Carlo based mathematical model.Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?
P2860
Q26827571-E33D8755-73BD-46C4-9EC0-24D0CDEFA3D1Q27021838-F3A8EA82-2A31-47B5-97B3-4EF019836436Q33973367-0524C425-67B7-4527-904D-80CD7110ABDDQ33973399-EDEBEF45-A3AD-4C05-AC3F-ABB236980530Q34936005-B410EC48-B9D0-423F-97C8-CF76125A8539Q35111985-EECF5207-A2FB-46FD-84EE-F18BEAF84D13Q35186819-BFE6330D-510E-4026-98DF-916198E0723AQ35783387-09CA6A5F-A469-45CF-B70D-233AE0704E71Q35971034-2C15EA4A-EE53-4758-924A-15F115357FA7Q36024114-CE641567-C519-46BF-8B50-19ABEB60ADE4Q36286485-270B3C9B-854B-4FAF-92C9-026156EBD4DAQ36327908-7F7A9C89-76A5-4B70-A4CB-B86D8239BDD1Q36596311-74A1D213-2373-40AA-AAC1-7C6410FE170EQ36689709-939D3ABB-7027-46BC-9DBA-151523896FE7Q37011261-51ACC953-933A-46DE-8AEA-7A7AED3F2457Q37016566-264AF550-CEB3-49CB-AF19-B426C1F53BC7Q37082395-9AE9C289-FB29-49A1-9F68-C793782E7E60Q37123469-989FE412-DC68-412E-8FC9-B2B71924FC16Q37345402-B5481ADE-7649-460C-90F9-45AAC79ED59AQ37732292-BB8E79D9-E5D0-46F7-8617-161D00BCD5ACQ38016163-7BE451FE-C61F-4873-AA52-A1D22BDA60F9Q38155852-992B003D-1F6D-4C3A-A461-26012F206CDEQ40027009-97A58DCB-96DE-441F-84A1-F8BB6A95501CQ40255849-6CB40482-08B3-4635-AF99-B6FBFE785219Q40582118-7A8C20E4-3347-45F4-A80E-AFBC55CA90CAQ41677756-EE9462D3-E47F-4D47-81D8-AEF5EFD34CB3Q41856102-3DBF1550-641B-4139-A64B-6209D5474953Q42115374-7CDB1F89-AAB2-4008-8FEC-A2BF1B64B75AQ42232269-908C641A-BFB0-49D5-B537-283A17A273E0Q42733479-C9D1F511-DDD9-4658-B0AE-A154908F682CQ42945884-5BD064E9-53BF-4D94-8BB1-497D3F53FD0BQ43183480-461B01D3-8778-4943-9896-CE533C5A251FQ44070976-361331BA-F572-4253-BD53-C1A50B891D0DQ44644593-2015A4F5-CF38-4CCC-8225-4DF6EFDB3C41Q46873535-DBC7E713-BA58-4CB4-B5B6-227A14CDCE43Q47138202-23957ADC-09A9-49F3-97BF-88534ECD5ED0Q47182931-475C4CC3-5C66-4379-B050-735DF9C5C56FQ48402423-9D0E0880-4201-44A1-AC4E-286EF0B8871CQ50149774-F2A95EC4-2FBC-45D6-865D-F34366976019Q53036226-4D5A1FCA-F98B-4AE8-A938-85EA20058E8C
P2860
F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@en
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@nl
type
label
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@en
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@nl
prefLabel
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@en
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@nl
P2093
P2860
P1433
P1476
F-18 fluorodeoxyglucose positr ...... and high impact on treatment.
@en
P2093
Mac Manus MP
Matthews JP
McKenzie A
Salminen E
P2860
P304
P356
10.1002/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V
P407
P577
2001-08-01T00:00:00Z